Sphingosine 1-phosphate signalling in cancer

Biochemical Society Transactions

Volumn 40, Issue 1, 2012, Pages 94-100

  Pyne, Nigel J ^a   Tonelli, Francesca ^a   Lim, Keng Gat ^a   Long, Jaclyn S ^a   Edwards, Joanne ^b   Pyne, Susan ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cancer; FTY720; G protein coupled receptor; Metastasis; Sphingosine 1 phosphate; Sphingosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FINGOLIMOD; PROTEIN INTERACTING WITH PROTEIN KINASE C; RECEPTOR; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 1 RECEPTOR; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER INVASION; DRUG MECHANISM; DRUG RESEARCH; HUMAN; NEOPLASM; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; LYSOPHOSPHOLIPIDS; NEOPLASMS; ONCOGENES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, ESTROGEN; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84856248243     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20110602     Document Type: Review

References (45)

1. Pyne, S. and Pyne, N.J. (2000) Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 349, 385-402 (Pubitemid 30465772)
2. Vadas, M., Xia, P., McCaughan, G. and Gamble, J. (2008) The role of sphingosine kinase-1 in cancer: oncogene or non-oncogene addiction. Biochim. Biophys. Acta 1781, 442-447
3. Pyne, N.J. and Pyne, S (2010) Sphingosine 1 phosphate and cancer. Nat. Rev. Cancer 10, 489-503
4. Long, J.S., Edwards, J., Watson, C., Tovey, S., Mair, K., Schiff, R., Natarajan, V., Pyne, N.J. and Pyne, S. (2010) Sphingosine kinase 1 induces tolerance to human Epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor positive breast cancer cells. Mol. Cell. Biol. 30, 3827-3841
5. 3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. Am. J. Pathol. 177, 2205-2215
6. Rayala, S.K. and Kumar, R. (2007) Sliding p21-activated kinase 1 to nucleus impacts Tamoxifen sensitivity. Biomed. Pharmacother. 61, 408-411 (Pubitemid 47239343)
7. Borg, A., Tandon, A.K. and Sigurdsson, H. (1990) HER2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res. 50, 4332-4337 (Pubitemid 20225674)
8. Shou, J., Massarweh, S., Osborne, C.K., Wakeling, A.E., Ali, S., Weiss, H. and Schiff, R (2004) Mechanisms of Tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J. Natl. Cancer Inst. 96, 926-935 (Pubitemid 38868139)
9. Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S. and Burtin, P. (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discovery 9, 883-897
10. Tonelli, F., Lim, K.G., Loveridge, C., Long, J., Pitson, S.M., Tigyi, G., Bittman, R., Pyne, S and Pyne, N.J. (2010) FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promotes its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell. Signalling 22, 1536-1542
11. Paugh, S.W., Paugh, B.S., Rahmani, M., Kapitonov, D., Kordula, T., Milstien, S., Adams, J.K., Zipkin, R.E., Grant, S. and Spiegel, S. (2008) A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukaemia. Blood 112, 1382-1391
12. Loveridge, C., Tonelli, F., Leclecq, T., Lim, K.G., Long, S., Berdyshev, E., Tate, R.J., Natarajan, V., Pitson, S.M., Pyne, N.J. and Pyne, S. (2010) The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells. J. Biol. Chem. 285, 38841-38852
13. Lim, K.G., Tonelli, F., Li, Z., Lu, X., Bittman, R., Pyne, S. and Pyne, N.J. (2011) FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation and actin rearrangement in MCF-7 breast cancer cells. J. Biol. Chem. 286, 18633-18640
14. Valentine, W.J., Kiss, G.N., Liu, J., Shuyu, E., Gotoh, M., Murokami-Murofushi, K., Pham, T.C., Baker, D., Parrill, A.B., Lu, X. et al. (2010) (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, signals as a pan-antagonist of sphingosine 1-phosphate GPCR and inhibits autotaxin activity. Cell. Signalling 22, 1543-1553
15. Lahiri, S., Park, H., Laviad, E.L., Lu, X., Bittman, R. and Futerman, A.H. (2009) Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an acyl-CoA chain length-dependent manner. J. Biol. Chem. 284, 16090-16098
16. Woodcock, J.M., Ma, Y., Coolen, C., Pham, D., Jones, C., Lopez, A.F. and Pitson, S.M. (2010) Sphingosine and FTY720 directly bind pro-survival 14-3-3 proteins to regulate their function. Cell. Signalling 22, 1291-1299
17. Dawson, G. and Qin, J. (2011) Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants. Biochem. Biophys. Res. Commun. 404, 321-323
18. 2 independently of sphingosine-1-phosphate receptors. Blood 109, 1077-1085
19. Nagaoka, Y., Otsuki, K., Fujita, T. and Uesato, S. (2008) Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells. Bio. Pharm. Bull. 6, 1177-1181 (Pubitemid 351871174)
20. Akao, Y., Banno, Y., Nakagawa, Y., Hasegawa, N., Kim, T., Murate, T., Igarashi, Y. and Nozawa, Y. (2006) High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem. Biophys. Res. Commun. 342, 1284-1290
21. Pchejetski, D., Doumerc, N., Golzio, M., Naymark, M., Teissié, J., Kohama, T., Waxman, J., Malavaud, B. and Cuvillier, O (2008) Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol. Cancer Ther. 7, 1836-1845
22. Dayon, A., Brizuela, L., Martin, C., Mazerolles, C., Pirot, N., Doumerc, N., Nogueira, L., Golzio, M., Teissié, J., Serre, G. et al. (2009) Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival. PLoS ONE 4, e8408
23. Nava, V.E., Cuvillier, O., Edsall, L.C., Kimura, K., Milstien, S., Gelmann, E.P. and Spiegel, S. (2000) Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 60, 4468-4474 (Pubitemid 32103627)
24. Pchejetski, D., Golzio, M., Bonhoure, E., Calvet, C., Doumerc, N., Garcia, V., Mazerolles, C., Rischmann, P., Teissié, J., Malavaud, B. and Cuvillier, O. (2005) Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res. 65, 11667-11675 (Pubitemid 41821727)
25. Kihara, A., Anada, Y. and Igarashi, Y. (2005) Mouse sphingosine kinase isoforms SPHK1a and SPHK1b differ in enzymatic traits including stability, localization, modification, and oligomerization. J. Biol. Chem. 281, 4532-4539 (Pubitemid 43847885)
26. 2 receptors mediate inhibition of glioma cell migration through Rho signalling pathways independent of PTEN. Biochem. Biophys. Res. Comm. 366, 963-968
27. Fisher, K.E., Pop, A., Koh, W., Anthis, N.J., Saunders, W.B. and Davis, G.E. (2006) Tumour cell invasion of collagen matrices requires coordinate lipid agonist-induced G protein and membrane-type matrix metalloproteinase-1-dependent signalling. Mol. Cancer 5, 69
28. Yamashita, H., Kitayama, J., Shida, D., Yamaguchi, H., Mori, K., Osada, M., Aoki, S., Yatomi, Y., Takuwa, Y. and Nagawa, H. (2006) Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation. J. Surg. Res. 130, 80-87 (Pubitemid 43028568)
29. 2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. Cancer Res. 69, 8686-8692
30. Alderton, F., Rakhit, S., Kong, K.-C., Palmer, T., Sambi, S., Pyne, S. and Pyne, N.J. (2001) Tethering of the platelet-derived growth factor βreceptor to G-protein coupled receptors: a novel platform for integrative signalling by these receptor classes in mammalian cells. J. Biol. Chem. 276, 28578-28585 (Pubitemid 37391573)
31. Pyne, N.J. and Pyne, S (2008) Sphingosine 1 phosphate, lysophosphatidic acid and growth factor signalling and termination. Biochim. Biophys. Acta 1781, 467-476
32. Waters, C., Connell, M.C., Pyne, S. and Pyne, N.J. (2005) c-Src is involved in regulating signal transmission from PDGFβ receptor-GPCR(s) complexes in mammalian cells. Cell. Signalling 17, 263-277 (Pubitemid 39371053)
33. Waters, C., Sambi, B., Kong, K.-C., Thompson, D., Pitson, S.M., Pyne, S. and Pyne, N.J. (2003) Sphingosine 1-phosphate and platelet-derived growth factor (PDGF) act via PDGFβ receptor-sphingosine 1-phosphate receptor complexes in airway smooth muscle. J. Biol. Chem. 278, 6282-6290 (Pubitemid 36800885)
34. Waters, C.M., Long, J.S., Gorshkova, I., Fujiwara, Y., Connell, M.C., Belmonte, K.E., Tigyi, G., Natarajan, V., Pyne, S. and Pyne, N.J. (2006) Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1. FASEB J. 20, 509-511 (Pubitemid 46671232)
35. Bergelin, N., Löf, C., Balthasar, S., Kalhori, V. and Törnquist, K. (2010) S1P1 and VEGFR-2 form a signalling complex with extracellularly regulated kinase 1/2 and protein kinase Cα regulating ML-1 thyroid carcinoma cell migration. Endocrinology 151, 2994-3005
36. Xia, P., Gamble, J.R., Wang, L., Pitson, S.M., Moretti, P.A., Wattenberg, B.W., D'Andrea, R.J. and Vadas, M.A. (2000) An oncogenic role of sphingosine kinase. Curr. Biol. 10, 1527-1530 (Pubitemid 32003646)
37. Leclercq, T.M., Moretti, P.A. and Pitson, S.M. (2011) Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis. Oncogene 30, 372-378
38. Long, J.S., Fujiwara, Y., Edwards, J., Tannahill, C., Tigyi, G., Pyne, S. and Pyne, N.J. (2010) Sphingosine 1-phosphate 4 uses HER2 (ErbB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. J. Biol. Chem. 285, 35957-35966
39. Shida, D., Kitayama, J., Yamaguchi, H., Yamashita, H., Mori, K., Watanabe, T. and Nagawa, H (2005) Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells. Biochem. Biophys. Res. Commun. 327, 907-914 (Pubitemid 40092834)
40. Oskouian, B., Sooriyakumaran, P., Borowsky, A.D., Crans, A., Dillard-Telm, L., Tan, Y.Y., Bandhuvula, P. and Saba, J.D. (2006) Sphingosine 1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc. Natl. Acad. Sci. U.S.A. 103, 17384-17389 (Pubitemid 44788978)
41. Ramaswamy, S., Ross, K.N., Lander, E.S. and Golub, T.R. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (Pubitemid 36068681)
42. Hibbs, K., Skubitz, K.M., Pambuccian, S.E., Casey, R.C., Burleson, K.M., Oegema, Jr, T.R., Thiele, J.J., Grindle, S.M., Bliss, R.L. and Skubitz, A.P. (2004) Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am. J. Pathol. 165, 397-414 (Pubitemid 38971371)
43. Bernardini, M., Lee, C.H., Beheshti, B., Prasad, M., Albert, M., Marrano, P., Begley, H., Shaw, P., Covens, A., Murphy, J. et al. (2005) High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia 7, 603-613 (Pubitemid 40967761)
44. Min, J., Van Veldhoven, P.P., Zhang, L., Hanigan, M.H., Alexander, H. and Alexander, S. (2005) Sphingosine 1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Mol. Cancer Res. 3, 287-296 (Pubitemid 40656816)
45. Johnson, K.R., Johnson, K.Y., Becker, K.P., Bielawski, J., Mao, C. and Obeid, L.M. (2003) Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. J. Biol. Chem. 278, 34541-34547 (Pubitemid 37553303)